(Q45012673)

English

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Japanese encephalitis virus

0 references

1 reference

based on heuristic

inferred from title

Japanese encephalitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Japanese encephalitis vaccine

1 reference

based on heuristic

inferred from title

hepatitis A vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Herwig Kollaritsch

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Ursula Wiedermann

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

A Kaltenböck

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

K Dubischar-Kastner

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

G Eder

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

W Jilg

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

C Klade

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

M Paulke-Korinek

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

F von Sonnenburg

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

M Spruth

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

E Schuller

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

0 references

publication date

30 May 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

33

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

4483-4489

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486955%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

The epidemiology of Japanese encephalitis: prospects for prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Further experience with Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Side-effects with Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Adverse reactions to Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Allergic mucocutaneous reactions to Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

A review of the long-term protection after hepatitis A and B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Assay of arbovirus neutralizing antibody by micro methods

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Estimating risk difference in multicenter studies under baseline-risk heterogeneity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Control of Japanese encephalitis--within our grasp?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Allergic reactions to Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

A case of imported JE acquired during short travel in Vietnam. Are current recommendations about vaccination broader?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Japanese encephalitis for a reference to international travelers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Response to hepatitis A vaccine in HIV-positive patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Comparative immunogenicity and tolerance of Vaqta and Havrix

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Interchangeability and tolerability of a virosomal and an aluminum-adsorbed hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Time course of hepatitis A antibody production after active, passive and active/passive immunisation: the results are highly dependent on the antibody test system used

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Evaluation of three commercial assays for the detection of hepatitis a virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.034

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45012673&oldid=2034639839"